Shares of Repros Therapeutics Inc. RPRX are higher on the session by 0.47%, currently trading at $6.39. The stock had been moving largely higher over the past four months and is currently trading above the 50-day and 200-day moving averages.
Options traders are buying puts on the name today. A short while ago the August 2011 $5.00 put was purchased 1,000 times, on the offer, on open interest of 2,460 contracts.
Overall put volume is now running at 2.44x the daily average with 100% of all puts traded being purchases on the offer.
Repros Therapeutics Inc. is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.